Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Current Cardiovascular Risk Reports|February 21, 2025
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular DiseaseSean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
JAMA|September 10, 2023
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical TrialLuke J Laffin, David Rodman, James M Luther, et al.
Journal of Cardiology|September 29, 2024
Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudyMaximilian C Volk, Saeid Mirzai, Ian Persits, et al.
International Heart Journal|May 1, 2020
Opioid Use and Morbidities during Left Ventricular Assist Device SupportPamela S Combs, Teruhiko Imamura, Umar Siddiqi, et al.
European Journal of Preventive Cardiology|April 16, 2026
Lipoprotein(a), High-Sensitivity C-Reactive Protein, and Incident ASCVD Risk in Individuals Without Standard Modifiable Risk FactorsRichard Kazibwe, Christopher L Schaich, Jeff A Kingsley, et al.
The International Journal of Cardiovascular Imaging|February 17, 2018
Focused cardiac ultrasound as a predictor of readmission in acute decompensated heart failureLuke J Laffin, Amit V Patel, Narayan Saha, et al.
JACC. Case Reports|November 14, 2025
Combined MIRACLE2 and CAHP Scores Enhance Mortality Prediction in Out-of-Hospital Cardiac Arrest With STEMIKatherine A Burns, Saeid Mirzai, Zachary D Pruitt, et al.
European Journal of Preventive Cardiology|November 3, 2025
Longitudinal Trajectories of Albuminuria and Risk of Subclinical and Clinical Heart Failure, Atrial Fibrillation, and Coronary Heart Disease: the MESA StudySoroush Masrouri, Parag A Chevli, Michael P Bancks, et al.
Transplantation Proceedings|August 23, 2022
Outcomes Associated With COVID-19 Hospitalization in Heart Transplantation PatientsChristopher N Kanaan, Jean-Pierre Iskandar, Mohamed M Gad, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 30, 2019
Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trialMichael R Laffin, Hamid Tayebi Khosroshahi, Heekuk Park, et al.
Pageof 12